![Thaminda Ramanayake](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thaminda Ramanayake
Directeur Général chez
Anaveon AG
Profil
Thaminda Ramanayake is currently Chief Executive Officer at Anaveon AG since 2026 and Venture Partner at Entree Capital since 2025.
Formerly, Mr. Ramanayake was Chief Business Officer at CureVac NV and Chief Business Officer at Affini-T Therapeutics, Inc. Education includes undergraduate studies at Berea College, graduate studies at the University of Rochester Medical Center, and an MBA from the University of Rochester Simon Business School.
Postes actifs de Thaminda Ramanayake
| Sociétés | Poste | Début |
|---|---|---|
Anaveon AG
 Anaveon AG BiotechnologyHealth Technology Develops biologics for cancer | Directeur Général | 23/03/2026 |
Entree Capital
 Entree Capital Investment ManagersFinance Entree Capital invests in companies located across the globe, primarily in Israel. The firm targets companies operating in the fields of SaaS, data, fintech, security, productivity and consumer. It provide financing for pre-seed, seed, early, later and buyout stage companies with an investment size of USD 0.25 - 3 million and also makes follow-on investments. | Private Equity Investor | 01/10/2025 |
Anciens postes connus de Thaminda Ramanayake
| Sociétés | Poste | Fin |
|---|---|---|
Affini-T Therapeutics, Inc.
 Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Corporate Officer/Principal | - |
| CUREVAC | Corporate Officer/Principal | - |
Formation de Thaminda Ramanayake
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Berea College
 Berea College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Rochester Medical Center
 University of Rochester Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entree Capital
Entree Capital Investment ManagersFinance Entree Capital invests in companies located across the globe, primarily in Israel. The firm targets companies operating in the fields of SaaS, data, fintech, security, productivity and consumer. It provide financing for pre-seed, seed, early, later and buyout stage companies with an investment size of USD 0.25 - 3 million and also makes follow-on investments. | Finance |
University of Rochester Simon Business School
 University of Rochester Simon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Develops biologics for cancer | Health Technology |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Health Technology |
